Revenue segments as reported by the company.

Premium and service revenues

Premium tax

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Depreciation

Amortization of acquired intangible assets

Premium tax expense

Health insurer fee expense

Impairment

Legal settlement

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Centene

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Centene exceeds earnings guidance, eyes growth in Marketplace products

Centene's Q4 2022 earnings call highlighted robust financial performance, successful execution of value-creation plans, and a focus on operational efficiency. While challenges in Medicare Advantage margins are anticipated, opportunities in the Marketplace business and cost-cutting initiatives offer avenues for growth. Strategic initiatives to address demographic shifts and enhance care relationships position Centene for future success.

Centene reports strong Q1 earnings, focuses on growth opportunities

Centene's Q1 performance reflects strength in financial results and a strategic outlook for future growth.
Despite challenges in Medicare profitability and Medicaid redeterminations, Centene remains focused on maximizing membership and maintaining high margins.
Opportunities in enhancing relationships, investing in infrastructure, and updating margin assumptions position Centene for long-term success.

Centene reports strong Q2 earnings, raises 2023 outlook amidst challenges

Centene's Q2 earnings call showcased robust financial performance, operational efficiencies, and strategic wins in Medicaid and Marketplace segments. While facing challenges in cost trends and Star ratings strategy, the company is well-positioned for growth through revenue expansion and value-creation initiatives. Opportunities for engagement with key stakeholders and successful outreach efforts present avenues for continued success.

Centene exceeds Q3 earnings expectations, eyes growth opportunities in 2024

Centene's Q3 2023 earnings call highlighted strong financial performance, progress in Medicaid redeterminations, and operational advancements. The company anticipates continued growth in adjusted EPS for 2023 and 2024, with a focus on margin expansion and operational efficiencies. Challenges include managing membership declines and addressing questions on business plans and cost implications.

Centene exceeds 2023 expectations, poised for growth in 2024

Centene's 2023 performance was strong, exceeding expectations and positioning the company for continued growth. Key initiatives in Medicaid, Medicare Advantage, and Marketplace are driving revenue growth and operational efficiency. Challenges in managing utilization trends and achieving target margins require ongoing attention.

Centene surpasses Q1 earnings expectations, eyes growth in Medicaid and Marketplace

Centene's Q1 performance exceeded expectations, showcasing strength in Medicaid and Marketplace segments.
While facing challenges in contract protests and operational clarity, the company's strategic focus on Medicare Advantage and growth opportunities remain key strengths.
With a robust financial outlook and ongoing initiatives for optimization, Centene is well-positioned for continued success in the healthcare market.
Investors can be optimistic about Centene's growth trajectory, supported by strong operational performance and strategic initiatives.

Centene reports robust Q2 earnings, eyes Medicaid rebound and Medicare growth

Centene's Q2 2024 earnings call highlighted strong performance, Medicaid challenges, and growth opportunities in Medicaid and Medicare markets. Leadership transitions and focus on program innovation are key areas of development for the company.

Centene surpasses Q3 earnings expectations, eyes growth amid challenges

Centene's Q3 performance exceeded expectations, driven by improvements in Medicaid and strong Medicare and Marketplace segments.
Despite challenges in Medicaid and competitive pressures, Centene remains confident in its future growth and operational enhancements.
The company's strategic focus on AI, margin expansion, and quality improvement positions it well for continued success and profitability.
Analyst inquiries and company responses highlighted key areas of focus and potential areas for improvement and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Shares of Centene Corp (NYSE: CNC) are up 4.0% on Tuesday after the managed care company said it reached a deal with activist investor Politan Capital Management. Centene to appoint five new directors to the board As part of the agreement, Centene appointed four new directors to its board, two of whom were nominated by […] The post This managed care company up 30% this year is ‘not an expensive stock' appeared first on Invezz.

This managed care company up 30% this year is ‘not an expensive stock'

Shares of Centene Corp. CNC, -0.38% gained 0.4% in premarket trading on Monday after the managed care company announced that its CEO is stepping down, its board will have five new members, and it signed a cooperation agreement with Politan Capital Management, a hedge fund. Michael Neidorff will retire in 2022 from his role as chairman and CEO.

Centene CEO to retire and five newly named board members will find his replacement

ST. LOUIS, Dec. 14, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("Centene") announced various enhancements today as part of its ongoing board refreshment and governance review process and a cooperation agreement the Company has entered into with Politan Capital Management ("Politan"). The Board of Directors will appoint five new directors: Ken Burdick, Christopher Coughlin, Wayne DeVeydt, and Theodore Samuels, as well as a fifth director to be mutually agreed upon by Centene and Politan.

CENTENE ANNOUNCES GOVERNANCE AND BOARD OF DIRECTORS CHANGES

ST. LOUIS, Dec. 14, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("Centene") today announced Chairman and CEO Michael Neidorff's intent to retire in 2022 as CEO. Upon his retirement as CEO, he will serve as Executive Chairman until the end of 2022.

CENTENE ANNOUNCES LEADERSHIP SUCCESSION PLAN

Centene (CNC) expects bottom-line growth to be supported by lower expenses and gross margin improvement.

Centene (CNC) Up 4.8% on Upbeat '22 Guidance: Key Details

The stock price of Centene Corp (NYSE: CNC) increased by 4.78% in the previous trading session. This is why it happened.

Centene Stock (CNC): Why The Price Increased

Shares of Centene Corp. CNC, +1.34% rose 1.3% in premarket trading Friday, after the health care company provided a 2022 revenue outlook that was above expectations. The company also said it was evaluating strategic alternatives for its international business, as part of its plan to optimize its portfolio of businesses, and said it expects share repurchases to play "a more meaningful role" next year in terms of returning value to shareholders.

Centene's stock rises after 2022 revenue outlook was above expectations

ST. LOUIS, Dec. 10, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today will host its investor day virtually and outline its 2022 financial guidance as well as provide details of its Value Creation Plan, designed to deliver enhanced earnings growth and create long-term shareholder value. "Centene has delivered strong results during 2021 as we extended our position as a leading healthcare enterprise committed to transforming the health of the community, one person at a time.

CENTENE CORPORATION ANNOUNCES 2022 GUIDANCE AND DETAILS VALUE CREATION PLAN

ST. LOUIS, Dec. 6, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced that its 2022 Financial Guidance and Investor Day event, scheduled for Friday, December 10, 2021, will now be held only in a virtual format, out of an abundance of caution over the COVID-19 Omicron variant. The company previously planned for a hybrid event, with limited in-person attendance.

Centene Corporation's 2022 Financial Guidance And Investor Day Event On December 10, 2021 Will Now Be Held Virtually

SACRAMENTO, Calif.--(BUSINESS WIRE)--Health Net Appoints Colin Havert to Lead Commercial Business

Health Net Appoints Colin Havert to Lead Commercial Business

Centene (CNC) reported earnings 30 days ago. What's next for the stock?

Centene (CNC) Up 7.2% Since Last Earnings Report: Can It Continue?

Johnson & Johnson

Morgan Stanley

"I'd rather find companies that did well in earnings season and got trampled on unjustly in the last few weeks," the "Mad Money" host said.

Jim Cramer picks 4 stocks to look at as market rotates away from tech winners

ST. LOUIS, Nov. 16, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today its Arizona subsidiaries Arizona Complete Health-Complete Care Plan and Care1st Health Plan Arizona were selected by the Arizona Health Care Cost Containment System (AHCCCS) for a Competitive Contract Expansion (CCE) to continue providing access to physical and behavioral healthcare services to Title XIX/XXI eligible persons with Serious Mental Illness (SMI) and to administer the state's crisis system, grant-funded services, and court-ordered evaluations. The new three-year agreement, with the possibility of two, two-year extensions, is anticipated to begin Oct. 1, 2022.

Centene Arizona Subsidiaries Awarded Contract Expansion to Continue Serving Arizonans with Serious Mental Illness

Centene has lower margins compared to its peers, but Politan may help it catch up to the competition.

How activist investor Politan Capital can raise profitability and bring fresh perspectives to Centene

ST. LOUIS, Nov. 10, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at the Wolfe Research Virtual Healthcare Conference, to be held November 17-18, 2021. Centene will participate in a virtual format on Wednesday, November 17 th at 11:00 a.m.

Centene To Present At Wolfe Research Virtual Healthcare Conference

ST. LOUIS, Nov. 4, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at the Credit Suisse 30th Annual Healthcare Conference, to be held November 8-11, 2021. Centene will participate in a virtual format on Wednesday, November 10 th at 10:30 a.m.

Centene To Present At Credit Suisse 30th Annual Healthcare Conference

ST. LOUIS, Nov. 3, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today issued the following statement with regard to Politan Capital Management: Centene's Board of Directors and management team are committed to acting in the best interests of the Company and its shareholders – and deliver substantial, sustainable value.  We welcome constructive ideas to enhance these efforts.

Centene Issues Comment with Regard to Politan

SACRAMENTO, Calif.--(BUSINESS WIRE)--Health Net, a California-based health plan with award-winning customer service and a decade of experience driving health equity, announced that California residents can choose one of several Ambetter from Health Net health plans for affordable family and individual health coverage. The plans are available to qualifying persons on CoveredCalifornia.com. “The disruption and uncertainty caused by the national pandemic proved that Californians need affordable an

Californians can Choose Ambetter from Health Net for Affordable Family and Individual Health Coverage

ST. LOUIS, Nov. 3, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that it has signed a definitive agreement to sell a majority stake in U.S. Medical Management, LLC (USMM) to Rubicon Founders; Valtruis, a WCAS company; Oak HC/FT; and HLM Venture Partners. Centene will retain a minority stake in USMM.

Centene Sells Majority Stake In U.S. Medical Management

ST. LOUIS, Nov. 2, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at the Bernstein Second Annual Operational Decisions Conference, to be held November 3-4, 2021. Centene will participate in a virtual format on Wednesday, November 3 rd at 3:30 p.m.

Centene To Present At Bernstein's 2nd Annual Operational Decisions Conference

The stock price of Centene, a full-line managed services company which services both government sponsored and private insurance health care programs, has seen a rise of 11% in a month (twenty-one trading days). The company recently reported upbeat Q3 results, with revenue of $32.4 billion and EPS.

What's Next For Centene Stock After An Upbeat Q3?

ST. LOUIS, Oct. 29, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) will host its 2022 Financial Guidance and Investor Meeting on Friday, December 10, 2021. The event will be presented in a hybrid format, with sell-side analysts invited to attend in person in New York City, accompanied by a simultaneous webcast, streamed live on the Company's website at www.centene.com, under the Investors section.

Centene Corporation To Host Hybrid 2022 Financial Guidance And Investor Meeting On December 10, 2021

Centene Corporation (NYSE: CNC)  has reported Q3 adjusted EPS of $1.26, slightly beating the consensus estimate of $1.25. Sales increased 11% Y/Y to $32.4 billion, ahead of the consensus of $31.62 billion.

Centene Raises Sales Outlook, Narrows Earnings Guidance For FY21

Centene Corporation (CNC) CEO Michael Neidorff on Q3 2021 Results - Earnings Call Transcript

Centene (CNC) delivered earnings and revenue surprises of -2.33% and 1.85%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

News for Centene Stock (CNC)